First robotic insertion of a perimodilar cochlear implant in a child and an adult

An insertion of perimodilar cochlear implant was performed with the assistance of the RobOtol® in a child at the Robert-Debré Hospital et an adult at the Pitié-Salpêtrière Hospital, both AP-HP hospitals.

Operation in the hospital operating room, with ENT surgeons Yann Nguyen and Ghizlene Lahlou.

@Institut reConnect - AP-HP

This robotic arm, made for micro-surgery of the inner middle ear, offers a better preservation of the cochlear structures, reduces post-operation complications and access for patients to more complex and higher-performance implants.

The implementation of this innovative technique is based on preclinical work carried out at the reConnect Institute, a foundation hosted by the Institut Pasteur, a center of excellence for hearing and speech disorders.

Read the AP-HP’s press release: https://www.aphp.fr/actualite/double-premiere-mondiale-lap-hp-linsertion-robotisee-dun-implant-cochleaire-perimodiolaire

Watch the report: "Je vais entendre à nouveau" : une femme et un bébé bénéficient d'une première mondiale dans deux hôpitaux parisiens | TF1 INFO

At the Hearing Institute, site of the reConnect Institute, the “Technologies and gene therapy for deafness” team co-directed by Saaid Safieddine, CNRS research director and Yann Nguyen, clinical director of the reConnect Institute and PU-PH, Sorbonne Universite are exploring:

• Gene therapy to develop therapeutic recombinant viral vectors to target different forms of genetic deafness, evaluate their efficacy, particularity and innocuousness.

• Robot assistance for ontological surgery with the RobOtol®. The aim is to optimize each operating step in the robotized surgical procedure of the middle and inner ear, simplifying the surgical gesture, increasing its safety and reducing the operating time.

To know more about the work of the reConnect Institute’s team at the Hearing Institute: https://research.pasteur.fr/en/team/technologies-and-gene-therapy-for-deafness/